-
-
Pharmaceuticals in Netherlands (2011) – Market Sizes
Segmentation of this market
Compound annual growth rates
Compound annual growth rate (CAGR) is provided for this market and is based on the last 5 years of available data.
Socio-economic data
Included with this snapshot is socio-economic data for Ireland. Population, Consumer Price Index (CPI), Gross Domestic Product (GDP), Exchange Rates.
Market Size & Forecast
Market size for Pharmaceuticals in Netherlands is given in %, EUR and USD with a minimum of five years' historical data. Market Forecast is provided for five years.
Definitions
Market size
- Highlights
- Figure 1: Value in Local Currency - Value (2005 - 2015)
- Figure 2: Value in Local Currency - Value growth (2005 - 2015)
- Table 1: Value in Local Currency (2005 - 2015)
- Figure 3: Value in USD - Value (2005 - 2015)
- Figure 4: Value in USD - Value growth (2005 - 2015)
- Table 2: Value in USD (2005 - 2015)
Market segmentation
- Figure 5: Netherlands - Pharmaceuticals: Market segmentation by value (bn EUR) (2007 - 2010)
- Table 3: Netherlands - Pharmaceuticals: Market segmentation by value (bn EUR) (2007 - 2010)
Market shares
- Figure 6: Netherlands - Pharmaceuticals: Company market share by value (%) - 2010
- Table 4: Netherlands - Pharmaceuticals: Company market share by value (%) (2010)
Company details
- Table 5: Netherlands - Pharmaceuticals: Website Links
Compound annual growth rates
- Table 6: Compound annual growth rates (2006 - 2015)
Socio-economic data
- Figure 7: Population (millions) (2003 - 2015)
- Table 7: Population (millions) (2003 - 2015)
- Figure 8: Consumer price index (CPI) (2002 - 2015)
- Table 8: Consumer price index (CPI) (2002 - 2015)
- Figure 9: Gross domestic product (m USD) (2003 - 2015)
- Table 9: Gross domestic product (m USD) (2003 - 2015)
- Figure 10: Exchange rates (2003 - 2015)
- Table 10: Exchange rates (2003 - 2015)
Sources of Data
- Table 11: Netherlands - Pharmaceuticals: Sources of Data
Methodology
About Mintel
- Abbott Laboratories
- AstraZeneca PLC
- Boehringer Ingelheim GmbH
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Teva Pharmaceutical Industries Limited